Rockwell Medical (NASDAQ: RMTI) reported Q2 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $17.78 million versus the consensus estimate of $17.84 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.